8-K current report · filed Aug 13, 2026

Olema Pharmaceuticals, Inc. (OLMA) 8-K Current Report: August 13, 2026

Item 5.02Item EX-99.1Item 7.01OLMA overview

Short answer

Olema Pharmaceuticals, Inc. (OLMA) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). Jason O’Byrne became CFO, principal financial officer and principal accounting officer effective August 11, 2026.

Olema Pharmaceuticals, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Jason O’Byrne became CFO, principal financial officer and principal accounting officer effective August 11, 2026
  • Leadership experience includes Vir Biotechnology, Caribou Biosciences, Audentes Therapeutics and Roche, strengthening biopharma finance expertise
  • Annual base salary $545,000, with a 45% target performance bonus
  • Sign-on bonus totals $350,000, split between $250,000 after appointment and $100,000 after one year
  • Proposed inducement option for 650,000 shares, vesting over four years and creating potential shareholder dilution

Item 7.01 · Regulation FD Disclosure

  • Olema appointed Mr. O’Byrne as Chief Financial Officer effective August 13, 2026
  • CFO appointment may affect financial strategy, capital planning and investor communications
  • Leadership change is material for a clinical-stage biotechnology company reliant on external financing

Item EX-99.1 · Exhibit EX-99.1

  • Jason O’Byrne appointed CFO, succeeding prior finance leadership as Olema approaches pivotal OPERA-01 data
  • Executive brings IPO, capital markets, acquisition integration, and commercial-stage biotechnology experience
  • Appointment supports potential palazestrant launch and transition toward a fully integrated oncology company
  • Near-term investor focus: OPERA-01 Phase 3 data, palazestrant launch readiness, and capital allocation under new CFO നേതൃത്വ

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Olema Pharmaceuticals, Inc. 8-K filings

Get the next OLMA 8-K as it lands

Follow OLMA for push alerts, or ask the research agent what this filing means.